Rajni Agarwal MD
Pediatric Hematologic Oncology
Pediatric Stem Cell Transplant and Regenerative Medicine
Join to view full profile
725 Welch RdPalo Alto, CA 94304
Phone+1 650-497-8000
Fax+1 650-497-8959
Dr. Agarwal is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1994 - 1995- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1992
M.G.M. Medical CollegeClass of 1983
Certifications & Licensure
CA State Medical License 2001 - 2027
OH State Medical License 1994 - 2001
American Board of Pediatrics Pediatrics
Clinical Trials
- Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection
- CD34+ Cell Enriched and T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Mismatched Related Donors or Borderline Organ Function
- JSP191 Antibody Targeting Conditioning in SCID Patients Start of enrollment: 2017 Mar 20
Publications & Presentations
PubMed
- Begelomab (BEGESAND) Salvages Steroid-Resistant Acute GVHD in Pediatric Patients.David Shyr, Steven M Chirieleison, Sebastian Fernandez-Pol, Katja Weinacht, Rajni Agarwal
Journal of Clinical Medicine. 2026-05-28 - 9 citationsIrradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trial.Rajni Agarwal, Alice Bertaina, Charmaine Soco, Janel R Long-Boyle, Gopin Saini
Nature Medicine. 2025-09-01 - 20 citationsAntiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II intervent...Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, Paibel Aguayo-Hiraldo, Christopher C Dvorak
Nature Communications. 2024-04-18
Lectures
- Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)Cl...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Administration of BPX-501 Following Αβ-T and B-Cell Depleted Haplo-HSCT in Children with Transfusion-Dependent Thalassemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Stanford Makes Stem Cell Transplants Safer Without ChemoNovember 7th, 2025
Stanford Breakthrough: Stem Cell Transplants Without Toxic Chemo or RadiationAugust 22nd, 2025
Novel, Less Toxic, Stem Cell Transplant Prep Yields Successful OutcomesJuly 22nd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
